Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The drug discovery process is actually a lot like dating. You have a wide pool of potential candidates and put a lot of time and energy into weeding out the duds. A handful might make it past the ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism among scientists, investors and the general public. “Artificial intelligence ...

FDA published a draft guidance document on Jan. 2, 2025 that provides considerations for complying with 21 Code of Federal Regulations (CFR) 211.110 (1). This specific section of the CFR focuses on ...

The FDA's policy of publishing CRLs aims to enhance transparency and accelerate drug development by providing early access to regulatory feedback. The release of CRLs has elicited mixed reactions, ...

Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

It can take up to 15 years and about $2.5 billion to develop a new drug treatment, so anything with the potential to shorten this cycle is going to pique the interest of the pharma sector worldwide.

A groundbreaking type of artificial intelligence (AI) could speed up new drug development by around six years, researchers say. Cancer patients could get access to new medicines in half the current ...

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...